Recent reports of an increase in human metapneumovirus (HMPV) cases in China have drawn international attention, leading to travel concerns and online speculation about an “unknown virus.”
However, both the Chinese government and global health authorities, including the World Health Organization (WHO), have emphasized that there is no evidence of a significant global health threat.
HMPV is not a new virus, experts clarified. It has been circulating among humans for over 60 years and is a common cause of upper respiratory infections, especially during the winter season in the Northern Hemisphere.
Most HMPV infections are mild and self-limiting, and calling it an “unknown virus” has been dismissed as fear-mongering inconsistent with scientific facts.
Chinese authorities have reported that the overall scale of respiratory infections this year is lower than in 2023.
Influenza viruses remain the most common cause of respiratory illnesses, and infections tend to peak during winter.
To address public concerns, China’s health agencies have implemented robust surveillance measures for acute respiratory infections, sharing results with both the public and the WHO in a timely manner.
The Chinese government reiterated its commitment to protecting the health of its citizens and foreign nationals in the country.
Disease control experts have provided guidance on preventive measures, encouraging individuals to adopt science-based practices for personal and family health.
WHO has also confirmed that respiratory infection levels in China remain within the usual range, and there is no indication of a more serious global health issue.
China emphasized its dedication to ensuring a safe and convenient environment for travel, urging the public to focus on accurate information and avoid unnecessary alarm.
Both Chinese nationals and international visitors are encouraged to stay informed and take appropriate precautions to safeguard their health.
